Mutation Type Is Not Clinically Useful in Predicting Prognosis in Hypertrophic Cardiomyopathy

Landstrom, Andrew P.; Ackerman, Michael J.

doi:10.1161/circulationaha.110.954446

Cited by 146Cardiomyopathy and Myosin StudiesCardiovascular Effects of ExerciseGenomics and Rare Diseases

The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.

Mutation Type Is Not Clinically Useful in Predicting Prognosis in Hypertrophic Cardiomyopathy

Open access

Landstrom, Andrew P., Ackerman, Michael J.·2010·Circulation

DOI 10.1161/circulationaha.110.954446PMC PMC6309993

Open this paper in CoChat — free account Open PDF

Abstract

H ypertrophic cardiomyopathy (HCM), or clinically unex- plained hypertrophy of the heart, is a common genetic cardiovascular disorder marked by genetic and phenotypic heterogeneity.As the genetic mutations underlying the pathogenesis of this disease have been identified, investigators have attempted to link mutations to clearly defined alterations in survival in hopes of identifying prognostically relevant biomarkers of disease.While initial studies labeling particular MYH7-encoded beta myosin heavy chain and TNNT2encoded cardiac troponin T mutations as "malignant" or "benign" raised hopes for mutation-specific risk stratification in HCM, a series of subsequent investigations identified mutations in families with contradictory disease phenotypes.Furthermore, subsequent proband-based cohort studies indicated that the clinical prognostic relevance of individual mutations labeled as "malignant" or "benign" in large referral centers is negligible.Herein, we seek to summarize the controversy and dispute the notion that mutation-specific risk stratification in HCM is possible at the present time.We provide evidence for clinicians and basic scientists alike to move beyond simple mutation descriptors to a more nuanced understanding of HCM mutations which fully captures the multi-factorial nature of HCM disease expression. Response by Ho on p 2450Over the last 2 decades, the genetic underpinnings of heritable cardiovascular disease have begun to be unveiled, starting with the discovery of rare pathogenic mutations that cause cardiomy-opathies and cardiac channelopathies.The simple paradigm of Mendelian inheritance, while helpful in certain monogenic disease processes, is fundamentally incapable of explaining the entirety of how complex diseases express in the context of complex human physiology under the influence of a myriad of intrinsic and extrinsic variables.Our understanding of the intricate interplay between 1 such intrinsic variable, the genome, and the manifestation of disease was advanced significantly in the decoding of a handful of human's genomes in February of 2001.1,2 Despite the decade of research these discoveries have initiated, clinicians and scientists alike are only beginning to appreciate the impact of this revolution on our understanding of health and disease.One disease, hypertrophic cardiomyopathy (HCM), typifies this struggle, as we seek to integrate the role of genetic alterations into the variation we see in this sudden-deathpredisposing disease.Defined by clinically unexplained hypertrophy of the ventricular walls and/or septum, HCM affects approximately 1 in 500 persons and is the most common inherited cardiovascular disease.3 HCM is the most common cause of sudden cardiac death (SCD) in young athletes and a significant cause of sudden death in the young in general.4,5 A heterogeneous disease, HCM demonstrates phenotypic variation in the degree of hypertrophy (none to extreme), fibrosis and myocyte disarray (none to extreme), left ventricular (LV) outflow tract obstruction (none to severe), morphological subtype (reverse curve, sigmoid, and apical-HCM, for example), associated symptoms (none to debilitating symptoms refrac-The opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/circulationaha.110.954446

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The ability to predict clinical outcomes based on specific mutations in HCM patients is limited.
“Although the genetic basis of HCM has been identified and continues to be studied, the ability to predict clinical outcomes based on specific mutations in HCM patients is limited (3, 4, 11).”
From Distinct hypertrophic cardiomyopathy genotypes result in convergent sarcomeric proteoform profiles revealed by top-down proteomics (2020) · cites this paper as [3]
Genotype alone is not sufficient to predict clinical outcomes in HCM patients, given the multifactorial nature of the disease.
“Moreover, genotype alone is not sufficient to predict clinical outcomes in HCM patients, given the multifactorial nature of the disease (3, 11, 42).”
From Distinct hypertrophic cardiomyopathy genotypes result in convergent sarcomeric proteoform profiles revealed by top-down proteomics (2020) · cites this paper as [3]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Initial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216
The sequence of the human genome
Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., et al. (2001) · Science · doi:10.1126/science.1058040 · Cited by 13,909
Prevalence of Hypertrophic Cardiomyopathy in a General Population of Young Adults
Maron, B. J., Gardin, J. M., Flack, J. M., Gidding, S. S., Kurosaki, T., & Bild, D. E. (1995) · Circulation · doi:10.1161/01.cir.92.4.785 · Cited by 2,274
The Sequence of the Human Genome
Venter, J. C., Smith, H. O., & Adams, M. D. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2014.237016 · Cited by 1,665
A molecular basis for familial hypertrophic cardiomyopathy: A β cardiac myosin heavy chain gene missense mutation
Geisterfer-Lowrance, A. A. T., Kass, S., Tanigawa, G., Vosberg, H.-P., McKenna, W., Seidman, C. E., & Seidman, J. G. (1990) · Cell · doi:10.1016/0092-8674(90)90274-i · Cited by 1,380
Hypertrophic Cardiomyopathy
Richard, P., Charron, P., Carrier, L., Ledeuil, C., Cheav, T., Pichereau, C., Benaiche, A., Isnard, R., Dubourg, O., Burban, M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000066323.15244.54 · Cited by 1,276
Methods in molecular medicine.
CRAIG, R. K. (1987) · BMJ · doi:10.1136/bmj.295.6599.646 · Cited by 1,063
α-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcomere
Thierfelder, L., Watkins, H. C., MacRae, C. A., Lamas, R., McKenna, W. J., Vosberg, H.-P., Seidman, J. G., & Seidman, C. E. (1994) · Cell · doi:10.1016/0092-8674(94)90054-x · Cited by 1,034
The Management of Hypertrophic Cardiomyopathy
Spirito, P., Seidman, C. E., McKenna, W. J., & Maron, B. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703133361107 · Cited by 1,026
Mutations in the Genes for Cardiac Troponin T and α-Tropomyosin in Hypertrophic Cardiomyopathy
Watkins, H. C., McKenna, W. J., Thierfelder, L., Suk, H. J., Anan, R., O'Donoghue, A., Spirito, P., Matsumori, A., Moravec, C. S., Seidman, J. G., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504203321603 · Cited by 935
Sudden death in young athletes.
Maron, B. J., Roberts, W. C., McAllister, H. A., Rosing, D. R., & Epstein, S. E. (1980) · Circulation · doi:10.1161/01.cir.62.2.218 · Cited by 835
Characteristics and Prognostic Implications of Myosin Missense Mutations in Familial Hypertrophic Cardiomyopathy
Watkins, H. C., Rosenzweig, A., Hwang, D., Levi, T., McKenna, W. J., Seidman, C. E., & Seidman, J. G. (1992) · New England Journal of Medicine · doi:10.1056/nejm199204233261703 · Cited by 742
Mutations in the cardiac myosin binding protein–C gene on chromosome 11 cause familial hypertrophic cardiomyopathy
Watkins, H. C., Conner, D. A., Thierfelder, L., Jarcho, J. A., MacRae, C. A., McKenna, W. J., Maron, B. J., Seidman, J. G., & Seidman, C. E. (1995) · Nature Genetics · doi:10.1038/ng1295-434 · Cited by 589
Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle
Poetter, K., Jiang, H., Hassanzadeh, S., Master, S. R., Chang, A., Dalakas, M. C., Rayment, I., Sellers, J. R., Fananapazir, L., & Epstein, N. D. (1996) · Nature Genetics · doi:10.1038/ng0596-63 · Cited by 582
Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy
Kimura, A., Harada, H., Park, J.-E., Nishi, H., Satoh, M., Takahashi, M., Hiroi, S., Sasaoka, T., Ohbuchi, N., Nakamura, T., et al. (1997) · Nature Genetics · doi:10.1038/ng0897-379 · Cited by 576
Mapping a Gene for Familial Hypertrophic Cardiomyopathy to Chromosome 14q1
Jarcho, J. A., McKenna, W. J., Paré, J. A. P., Solomon, S. D., Holcombe, R. F., Dickie, S., Levi, T., Donis-Keller, H., Seidman, J. G., & Seidman, C. E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911163212005 · Cited by 537
Causes of sudden death in competitive athletes
Maron, B. J., Epstein, S. E., & Roberts, W. C. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80283-2 · Cited by 536
Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy
Driest, S. L. V., Vasile, V. C., Ommen, S. R., Will, M. L., Tajik, A. J., Gersh, B. J., & Ackerman, M. J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.07.045 · Cited by 423
Self-citation
α-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy
Mogensen, J., Klausen, I. C., Pedersen, A. K., Egeblad, H., Bross, P., Kruse, T. A., Gregersen, N., HANSEN, P. S., Baandrup, U. T., & Børglum, A. D. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6460 · Cited by 396
Diagnostic, Prognostic, and Therapeutic Implications of Genetic Testing for Hypertrophic Cardiomyopathy
Bos, J. M., Towbin, J. A., & Ackerman, M. J. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.075 · Cited by 392
Self-citation
Methods in molecular medicine
Sayan, B. S. (2004) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401459 · Cited by 389
Genetic Basis of Hypertrophic Cardiomyopathy: From Bench to the Clinics
Alcalai, R., Seidman, J. G., & Seidman, C. E. (2007) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2007.00965.x · Cited by 387
Sudden Death due to Troponin T Mutations
Moolman, J. C., Corfield, V. A., Posen, B., Ngumbela, K. C., Seidman, C. E., Brink, P. A., & Watkins, H. C. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00530-x · Cited by 387
Myofilament Protein Gene Mutation Screening and Outcome of Patients With Hypertrophic Cardiomyopathy
Olivotto, I., Girolami, F., Ackerman, M. J., Nistri, S., Bos, J. M., Zachara, E., Ommen, S. R., Theis, J. L., Vaubel, R. A., Re, F., et al. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.6.630 · Cited by 380
Self-citation
Structural Analysis of the Titin Gene in Hypertrophic Cardiomyopathy: Identification of a Novel Disease Gene
Satoh, M., Takahashi, M., Sakamoto, T., Hiroe, M., Marumo, F., & Kimura, A. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1221 · Cited by 325
Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy
Hayashi, T., Arimura, T., Satoh, M., Ueda, K., Hohda, S., Inagaki, N., Takahashi, M., Hori, H., Yasunami, M., Nishi, H., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.08.058 · Cited by 302
Hypertrophic Cardiomyopathy
Varnava, A. M., Elliot, P. M., BABOONIAN, C., Davison, F. D., Davies, M. J., & McKenna, W. J. (2001) · Circulation · doi:10.1161/hc3701.095952 · Cited by 298
Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy.
Anan, R., Greve, G., Thierfelder, L., Watkins, H. C., McKenna, W. J., Solomon, S. D., Vecchio, C., Shono, H., Nakao, S., & Tanaka, H. (1994) · Journal of Clinical Investigation · doi:10.1172/jci116957 · Cited by 285
Mechanical stress-strain sensors embedded in cardiac cytoskeleton: Z disk, titin, and associated structures
Hoshijima, M. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00816.2005 · Cited by 263
Mutations in the Human Muscle LIM Protein Gene in Families With Hypertrophic Cardiomyopathy
Geier, C., Perrot, A., Özcelik, C., Binner, P., Counsell, D., Hoffmann, K., Pilz, B., Martiniak, Y., Gehmlich, K., van der Ven, P. F. M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000056522.82563.5f · Cited by 245
Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin t genes in hypertrophic cardiomyopathy
Ackerman, M. J., VanDriest, S. L., Ommen, S. R., Will, M. L., Nishimura, R. A., Tajik, A. J., & Gersh, B. J. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01900-9 · Cited by 235
Self-citation
Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the beta-myosin heavy chain gene. A 908Leu----Val mutation and a 403Arg----Gln mutation.
Epstein, N. D., Cohn, G., Cyran, F., & Fananapazir, L. (1992) · Circulation · doi:10.1161/01.cir.86.2.345 · Cited by 230
Gene Mutations in Apical Hypertrophic Cardiomyopathy
Arad, M., Penas-Lado, M., Monserrat, L., Maron, B. J., Sherrid, M. V., Ho, C. Y., Barr, S. C., Karim, A., Olson, T. M., Kamisago, M., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.547448 · Cited by 227
Genotype-phenotype correlations in hypertrophic cardiomyopathy. Insights provided by comparisons of kindreds with distinct and identical beta-myosin heavy chain gene mutations.
Fananapazir, L., & Epstein, N. D. (1994) · Circulation · doi:10.1161/01.cir.89.1.22 · Cited by 226
Mutation spectrum in a large cohort of unrelated consecutive patients with hypertrophic cardiomyopathy
Erdmann, J., Dähmlow, S., Wischke, S., Senyuva, M., Werner, U., Raible, J., Tanis, N., Dyachenko, S., Hummel, M. W., Hetzer, R., et al. (2003) · Clinical Genetics · doi:10.1034/j.1399-0004.2003.00151.x · Cited by 225
Genotype–phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethonin
Bos, J. M., Poley, R. N., Ny, M., Tester, D. J., Xu, X., Vatta, M., Towbin, J. A., Gersh, B. J., Ommen, S. R., & Ackerman, M. J. (2005) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2005.10.008 · Cited by 195
Self-citation
Myozenin 2 Is a Novel Gene for Human Hypertrophic Cardiomyopathy
Osio, A., Tan, L., Chen, S. N., Lombardi, R., Nagueh, S. F., Shete, S. S., Roberts, R., Willerson, J. T., & Marian, A. J. (2007) · Circulation Research · doi:10.1161/01.res.0000263008.66799.aa · Cited by 194
Mutations in JPH2-encoded junctophilin-2 associated with hypertrophic cardiomyopathy in humans
Landstrom, A. P., Weisleder, N. L., Batalden, K. B., Bos, J. M., Tester, D. J., Ommen, S. R., Wehrens, X. H. T., Claycomb, W. C., Ko, J., Hwang, M., et al. (2007) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2007.04.006 · Cited by 182
Self-citation
Yield of Genetic Testing in Hypertrophic Cardiomyopathy
Driest, S. L. V., Ommen, S. R., Tajik, A. J., Gersh, B. J., & Ackerman, M. J. (2005) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)61527-9 · Cited by 181
Self-citation
Prevalence and Severity of “Benign” Mutations in the β-Myosin Heavy Chain, Cardiac Troponin T, and α-Tropomyosin Genes in Hypertrophic Cardiomyopathy
Driest, S. L. V., Ackerman, M. J., Ommen, S. R., Shakur, R., Will, M. L., Nishimura, R. A., Tajik, A. J., & Gersh, B. J. (2002) · Circulation · doi:10.1161/01.cir.0000042675.59901.14 · Cited by 180
Self-citation
Cardiac Ankyrin Repeat Protein Gene (ANKRD1) Mutations in Hypertrophic Cardiomyopathy
Arimura, T., Bos, J. M., Sato, A., Kubo, T., Okamoto, H., Nishi, H., Harada, H., Koga, Y., Moulik, M., Doi, Y., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.12.082 · Cited by 160
Self-citation
Homozygous Mutation in Cardiac Troponin T
Ho, C. Y., Lever, H. M., DeSanctis, R. W., Farver, C. F., Seidman, J. G., & Seidman, C. E. (2000) · Circulation · doi:10.1161/01.cir.102.16.1950 · Cited by 150
Molecular and functional characterization of novel hypertrophic cardiomyopathy susceptibility mutations in TNNC1-encoded troponin C
Landstrom, A. P., Parvatiyar, M. S., Pinto, J. R., Marquardt, M. L., Bos, J. M., Tester, D. J., Ommen, S. R., Potter, J. D., & Ackerman, M. J. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.05.003 · Cited by 134
Self-citation
Echocardiographic-determined septal morphology in Z-disc hypertrophic cardiomyopathy
Theis, J. L., Bos, J. M., Bartleson, V. B., Will, M. L., Binder, J. S., Vatta, M., Towbin, J. A., Gersh, B. J., Ommen, S. R., & Ackerman, M. J. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.119 · Cited by 118
Self-citation
Identification of a metavinculin missense mutation, R975W, associated with both hypertrophic and dilated cardiomyopathy☆
Vasile, V. C., WILL, M., Ommen, S. R., Edwards, W. D., Olson, T. M., & Ackerman, M. J. (2005) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2005.08.006 · Cited by 112
Self-citation
Clinical Features of Hypertrophic Cardiomyopathy Caused by a Lys183 Deletion Mutation in the Cardiac Troponin I Gene
Kokado, H., Shimizu, M., Yoshio, H., Ino, H., Okeie, K., Emoto, Y., Matsuyama, T., Yamaguchi, M., Yasuda, T., Fujino, N., et al. (2000) · Circulation · doi:10.1161/01.cir.102.6.663 · Cited by 105
Familial hypertrophic cardiomyopathy: a genetic model of cardiac hypertrophy
Watkins, H. C., Seidman, J. G., & Seidman, C. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.suppl_1.1721 · Cited by 104
A missense mutation in a ubiquitously expressed protein, vinculin, confers susceptibility to hypertrophic cardiomyopathy
Vasile, V. C., Ommen, S. R., Edwards, W. D., & Ackerman, M. J. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.04.151 · Cited by 102
Self-citation
Identification of the genotypes causing hypertrophic cardiomyopathy in northern Sweden
Mörner, S. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(03)00146-9 · Cited by 101
A new mutation of the cardiac troponin T gene causing familial hypertrophic cardiomyopathy without left ventricular hypertrophy
Varnava, A. M., BABOONIAN, C., Davison, F. D., Cruz, L., Elliot, P. M., Davies, M. J., & McKenna, W. J. (1999) · Heart · doi:10.1136/hrt.82.5.621 · Cited by 101
Myosin Light Chain Mutation Causes Autosomal Recessive Cardiomyopathy With Mid-Cavitary Hypertrophy and Restrictive Physiology
Olson, T. M., Karst, M. L., Whitby, F. G., & Driscoll, D. J. O. (2002) · Circulation · doi:10.1161/01.cir.0000018444.47798.94 · Cited by 99
Systematic analysis of the regulatory and essential myosin light chain genes: genetic variants and mutations in hypertrophic cardiomyopathy
Kabaeva, Z. T., Perrot, A., Wolter, B., Dietz, R., Cardim, N. M., Correia, J. M., Schulte, H. D., Aldashev, A. A., Mirrakhimov, M. M., & Osterziel, K. J. (2002) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200872 · Cited by 92
Cardiac troponin T mutation in familial cardiomyopathy with variable remodeling and restrictive physiology
Menon, S., Michels, V. V., Pellikka, P. A., Ballew, J. D., Karst, M., Herron, K. J., Nelson, S., Rodeheffer, R. J., & Olson, T. M. (2008) · Clinical Genetics · doi:10.1111/j.1399-0004.2008.01062.x · Cited by 89
Genetic screening of calcium regulation genes in familial hypertrophic cardiomyopathy
Chiu, C. L., Tebo, M., Ingles, J., Yeates, L., Arthur, J. W., Lind, J. M., & Semsarian, C. (2007) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2007.06.009 · Cited by 87
Novel missense mutation in α-tropomyosin gene found in Japanese patients with hypertrophic cardiomyopathy
Nakajima-Taniguchi, C. (1995) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(95)90026-8 · Cited by 80
Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the beta-myosin heavy chain gene. A 908Leu----Val mutation and a 403Arg----Gln mutation.
DEpstein, N., MCohn, G., FCyran, & LFananapazir (1992) · Circulation · Cited by 75
Malignant familial hypertrophic cardiomyopathy D166V mutation in the ventricular myosin regulatory light chain causes profound effects in skinned and intact papillary muscle fibers from transgenic mice
Kerrick, W. G. L., Kaźmierczak, K., Xu, Y., Wang, Y., & Szczesna‐Cordary, D. (2008) · The FASEB Journal · doi:10.1096/fj.08-118182 · Cited by 70
Novel Missense Mutation in Cardiac Troponin T Gene Found in Japanese Patient with Hypertrophic Cardiomyopathy
Nakajima-Taniguchi, C., Matsui, H., Fujio, Y., Nagata, S., Kishimoto, T., & Yamauchi‐Takihara, K. (1997) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1996.0322 · Cited by 67
Genotype: phenotype correlations in hypertrophic cardiomyopathy.
Watkins, H. C. (1998) · PubMed · Cited by 62
A new missense mutation, Arg719Gln, in the β-cardiac heavy chain myosin gene of patients with familial hypertrophic cardiomyopathy
Consevage, M. W., Salada, G. C., Baylen, B. G., Ladda, R. L., & Rogan, P. K. (1994) · Human Molecular Genetics · doi:10.1093/hmg/3.6.1025 · Cited by 52
Malignant Hypertrophic Cardiomyopathy Caused by the Arg723Gly Mutation in β -Myosin Heavy Chain Gene
Enjuto, M., Francino, A., Navarro‐López, F., Bertrán, D. V., Paré, J.-C., & Ballesta, A. M. (2000) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2000.1260 · Cited by 50
The val606met mutation in the cardiac beta-myosin heavy chain gene in patients with familial hypertrophic cardiomyopathy is associated with a high risk of sudden death at young age
Havndrup, O., Bundgaard, H., Andersen, P. S., Larsen, L. A., Vuust, J., Kjeldsen, K. P., & Christiansen, M. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01532-6 · Cited by 29
Familial hypertrophic cardiomyopathy: the same mutation, different prognosis. Comparison of two families with a long follow-up.
Brito, D. A., Richard, P., Isnard, R., Pipa, J. L., Michel Komajda, N., & Madeira, H. C. (2003) · PubMed · Cited by 29
Mutation Detection in Congenital Long QT Syndrome: Cardiac Channel Gene Screen Using PCR, dHPLC, and Direct DNA Sequencing
Tester, D. J., Will, M. L., & Ackerman, M. J. (2006) · Humana Press eBooks · doi:10.1385/1-59745-159-2:181 · Cited by 24
Self-citation
Mutation Detection in Congenital Long QT Syndrome
Tester, D. J., Will, M. L., & Ackerman, M. J. (2006) · Methods in molecular medicine · doi:10.1007/978-1-59745-159-8_13 · Cited by 22
Self-citation
Beta-myosin Heavy Chain Gene Mutations and Hypertrophic Cardiomyopathy in Austrian Children
Greber‐Platzer, S., Marx, M., Fleischmann, C., Suppan, C., Dobner, M., & Wimmer, M. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2000.1287 · Cited by 19

Flagged first, then by citations

Research works printed but not linked: 2

10.1056/NEJM199504203321603 · DOI
10.1016/S0025-6196(11)60890-2 · DOI

Sorted by citations

2023 ESC guidelines for the management of cardiomyopathies
Arbelo, E., Protonotarios, A., Gimeno, J. R., Arbustini, E., Barriales-Villa, R., Basso, C., Bezzina, C. R., Biagini, E., Blom, N. A., de Boer, R. A., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad194 · Cited by 2,844
Hypertrophic cardiomyopathy
Maron, B. J., & Maron, M. S. (2013) · The Lancet · doi:10.1016/s0140-6736(12)60397-3 · Cited by 1,231
Genetics of Hypertrophic Cardiomyopathy After 20 Years
Maron, B. J., Maron, M. S., & Semsarian, C. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.02.068 · Cited by 702
Calcium Signaling and Cardiac Arrhythmias
Landstrom, A. P., Dobrev, D., & Wehrens, X. H. T. (2017) · Circulation Research · doi:10.1161/circresaha.117.310083 · Cited by 596
Self-citation
Circulating miR-29a, Among Other Up-Regulated MicroRNAs, Is the Only Biomarker for Both Hypertrophy and Fibrosis in Patients With Hypertrophic Cardiomyopathy
Roncarati, R., Anselmi, C. V., Losi, M. A., Papa, L., Cavarretta, E., Martins, P. A. D. C., Contaldi, C., Jotti, G. S., Franzone, A., Galastri, L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.09.041 · Cited by 329
Mechanisms of disease: hypertrophic cardiomyopathy
Frey, N., Luedde, M., & Katus, H. A. (2012) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.159 · Cited by 235
A systematic review and meta-analysis of genotype–phenotype associations in patients with hypertrophic cardiomyopathy caused by sarcomeric protein mutations
Lopes, L. R., Rahman, M. S., & Elliot, P. M. (2013) · Heart · doi:10.1136/heartjnl-2013-303939 · Cited by 204
Moving Beyond the Sarcomere to Explain Heterogeneity in Hypertrophic Cardiomyopathy
Maron, B. J., Maron, M. S., Maron, B. A., & Loscalzo, J. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.01.061 · Cited by 161
Double or compound sarcomere mutations in hypertrophic cardiomyopathy: A potential link to sudden death in the absence of conventional risk factors
Maron, B. J., Maron, M. S., & Semsarian, C. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.08.009 · Cited by 160
Evolution evolves: physiology returns to centre stage
Noble, D., Jablonka, E., Joyner, M. J., Müller, G. B., & Omholt, S. W. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2014.273151 · Cited by 147
Genetics of hypertrophic cardiomyopathy: established and emerging implications for clinical practice
Lopes, L. R., Ho, C. Y., & Elliot, P. M. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae421 · Cited by 120
JCS/JHFS 2018 Guideline on the Diagnosis and Treatment of Cardiomyopathies
Kitaoka, H., Tsutsui, H., Kubo, T., Ide, T., Chikamori, T., Fukuda, K., Fujino, N., Higo, T., Isobe, M., Kamiya, C., et al. (2021) · Circulation Journal · doi:10.1253/circj.cj-20-0910 · Cited by 119
Distinct hypertrophic cardiomyopathy genotypes result in convergent sarcomeric proteoform profiles revealed by top-down proteomics
Tucholski, T., Cai, W., Gregorich, Z. R., Bayne, E. F., Mitchell, S. D., McIlwain, S. J., de Lange, W. J., Wrobbel, M., Karp, H., Hite, Z., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2006764117 · Cited by 107
Advanced Heart Failure With Preserved Systolic Function in Nonobstructive Hypertrophic Cardiomyopathy
Rowin, E. J., Maron, B. J., Kiernan, M. S., Casey, S. A., Feldman, D. S., Hryniewicz, K. M., Chan, R. H. M., Harris, K. M., Udelson, J. E., DeNofrio, D. D., et al. (2014) · Circulation Heart Failure · doi:10.1161/circheartfailure.114.001435 · Cited by 111
Hypertrophic Cardiomyopathy: A Review
Houston, B. A., & Stevens, G. R. (2014) · Clinical Medicine Insights Cardiology · doi:10.4137/cmc.s15717 · Cited by 101
Hypertrophic cardiomyopathy in children
Moak, J. P., & Kaski, J. P. (2012) · Heart · doi:10.1136/heartjnl-2011-300531 · Cited by 92
Genetics of hypertrophic cardiomyopathy: advances and pitfalls in molecular diagnosis and therapy
Fernandes, A. R., & Roma‐Rodrigues, C. (2014) · The Application of Clinical Genetics · doi:10.2147/tacg.s49126 · Cited by 89
Hypertrophic remodelling in cardiac regulatory myosin light chain ( MYL2 ) founder mutation carriers
Claes, G. R. F., van Tienen, F. H. J., Lindsey, P. J., Krapels, I. P. C., den Enden, A. T. J. M. H.-V., Hoos, M. B., Barrois, Y. E. G., Janssen, J. W. H., Paulussen, A. D. C., Sels, J.-W. E. M., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv522 · Cited by 78
Human Cardiac Organoids for Modeling Genetic Cardiomyopathy
Buono, M. F., von Boehmer, L., Strang, J., Hoerstrup, S. P., Emmert, M. Y., & Nugraha, B. (2020) · Cells · doi:10.3390/cells9071733 · Cited by 76
Abnormalities in sodium current and calcium homoeostasis as drivers of arrhythmogenesis in hypertrophic cardiomyopathy
Coppini, R., Santini, L., Olivotto, I., Ackerman, M. J., & Cerbai, E. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa124 · Cited by 74
Self-citation
Phenotype and prognostic correlations of the converter region mutations affecting the β myosin heavy chain
García-Giustiniani, D. A., Arad, M., Ortiz-Genga, M., Villa, R. B., Fernández, X., Rodrı́guez, I., Mazzanti, A., Veira, E., Maneiro, E., Rebolo-Bardanca, P., et al. (2015) · Heart · doi:10.1136/heartjnl-2014-307205 · Cited by 70
Malignant Effects of Multiple Rare Variants in Sarcomere Genes on the Prognosis of Patients with Hypertrophic Cardiomyopathy
Wang, J., Wang, Y., Zou, Y., Sun, K., Wang, Z., Ding, H., Yuan, J., Wei, W., Hou, Q., Wang, H., et al. (2014) · European Journal of Heart Failure · doi:10.1002/ejhf.144 · Cited by 69
Genetic Basis of End-Stage Hypertrophic Cardiomyopathy
García‐Pavía, P., Vázquez, M. E., Segovia, J., Salas, C., Avellana, P., Gómez-Bueno, M. F., Vilches, C., Gallardo, M. E., Garesse, R., Molano, J., et al. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr110 · Cited by 66
Genotype-Positive Status in Patients With Hypertrophic Cardiomyopathy Is Associated With Higher Rates of Heart Failure Events
Li, Q., Gruner, C., Chan, R. H. M., Care, M. E., Siminovitch, K. A., Williams, L. K., Woo, A., & Rakowski, H. (2014) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.113.000331 · Cited by 67
Multiple gene mutations, not the type of mutation, are the modifier of left ventricle hypertrophy in patients with hypertrophic cardiomyopathy
Zou, Y., Wang, J., Liu, X., Wang, Y., Chen, Y., Sun, K., Gao, S., Zhang, C., Wang, Z., Zhang, Y., et al. (2013) · Molecular Biology Reports · doi:10.1007/s11033-012-2474-2 · Cited by 64
Screening of MYH7, MYBPC3, and TNNT2 genes in Brazilian patients with hypertrophic cardiomyopathy
Marsiglia, J. D. C., Credidio, F. L., de Oliveira, T. G. M., Reis, R. F., Antunes, M. D. O., de Araujo, A. Q., Pedrosa, R. P., Ferreira, J. M. B. B., Mady, C., Krieger, J. E., et al. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.07.029 · Cited by 64
Mechanism of Progressive Heart Failure and Significance of Pulmonary Hypertension in Obstructive Hypertrophic Cardiomyopathy
Covella, M., Rowin, E. J., Hill, N. S., Preston, I. R., Milan, A., Opotowsky, A. R., Maron, B. J., Maron, M. S., & Maron, B. A. (2017) · Circulation Heart Failure · doi:10.1161/circheartfailure.116.003689 · Cited by 63
Evaluation of the Mayo Clinic Phenotype-Based Genotype Predictor Score in Patients with Clinically Diagnosed Hypertrophic Cardiomyopathy
Murphy, S. L., Anderson, J. H., Kapplinger, J. D., Kruisselbrink, T., Gersh, B. J., Ommen, S. R., Ackerman, M. J., & Bos, J. M. (2016) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-016-9681-5 · Cited by 61
Self-citation
Prevalence and Clinical Implication of Double Mutations in Hypertrophic Cardiomyopathy
Fourey, D., Care, M. E., Siminovitch, K. A., Weissler‐Snir, A., Hindieh, W., Chan, R. H. M., Gollob, M. H., Rakowski, H., & Adler, A. (2017) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.116.001685 · Cited by 60
Metabolic characterization of hypertrophic cardiomyopathy in human heart
Wang, W., Wang, J., Yao, K., Wang, S., Nie, M., Zhao, Y., Wang, B., Pang, H., Xu, J., Wu, G., et al. (2022) · Nature Cardiovascular Research · doi:10.1038/s44161-022-00057-1 · Cited by 58
A Mutation in TNNC1-encoded Cardiac Troponin C, TNNC1-A31S, Predisposes to Hypertrophic Cardiomyopathy and Ventricular Fibrillation
Parvatiyar, M. S., Landstrom, A. P., Figueiredo-Freitas, C., Potter, J. D., Ackerman, M. J., & Pinto, J. R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.377713 · Cited by 56
Self-citation
Primary Myocardial Fibrosis as an Alternative Phenotype Pathway of Inherited Cardiac Structural Disorders
Junttila, J. M., Holmström, L. T. A., Pylkäs, K., Mantere, T., Kaikkonen, K., Porvari, K., Kortelainen, M.-L., Pakanen, L., Kerkelä, R., Myerburg, R. J., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.032175 · Cited by 59
Hypertrophic Cardiomyopathy: How do Mutations Lead to Disease?
Marsiglia, J. D. C., & Pereira, A. C. (2014) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20140022 · Cited by 55
Distinguishing Hypertrophic Cardiomyopathy-Associated Mutations from Background Genetic Noise
Kapplinger, J. D., Landstrom, A. P., Bos, J. M., Salisbury, B. A., Callis, T. E., & Ackerman, M. J. (2014) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-014-9542-z · Cited by 53
Self-citation
Cardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem Cells
Tanaka, A., Yuasa, S., Node, K., & Fukuda, K. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160818894 · Cited by 52
β-Myosin Heavy Chain Variant Val606Met Causes Very Mild Hypertrophic Cardiomyopathy in Mice, but Exacerbates HCM Phenotypes in Mice Carrying Other HCM Mutations
Blankenburg, R., Hackert, K., Wurster, S., Deenen, R., Seidman, J. G., Seidman, C. E., Lohse, M. J., & Schmitt, J. P. (2014) · Circulation Research · doi:10.1161/circresaha.115.303178 · Cited by 49
Beyond the Cardiac Myofilament: Hypertrophic Cardiomyopathy- Associated Mutations in Genes that Encode Calcium-Handling Proteins
Landstrom, A. P., & Ackerman, M. J. (2012) · Current Molecular Medicine · doi:10.2174/156652412800620020 · Cited by 46
Self-citation
Two founder mutations in the alpha-tropomyosin and the cardiac myosin-binding protein C genes are common causes of hypertrophic cardiomyopathy in the Finnish population
Jääskeläinen, P., Heliö, T. M., Aalto‐Setälä, K., Kaartinen, M., Ilveskoski, E., Hämäläinen, L. I., Melin, J., Nieminen, M. S., Laakso, M., Kuusisto, J., et al. (2012) · Annals of Medicine · doi:10.3109/07853890.2012.671534 · Cited by 46
Sex differences in hypertrophic cardiomyopathy
van Driel, B., Nijenkamp, L. L. A. M., Huurman, R., Michels, M., & van der Velden, J. (2019) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000612 · Cited by 46
Interpreting Incidentally Identified Variants in Genes Associated With Catecholaminergic Polymorphic Ventricular Tachycardia in a Large Cohort of Clinical Whole-Exome Genetic Test Referrals
Landstrom, A. P., Schwartz, A. D., Rosenfeld, J. A., Yang, Y., McLean, M. J., Miyake, C. Y., Valdés, S. O., Fan, Y., Allen, H. D., Penny, D. J., et al. (2017) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.116.004742 · Cited by 43
Self-citation
Unraveling the Genotype‐Phenotype Relationship in Hypertrophic Cardiomyopathy: Obesity‐Related Cardiac Defects as a Major Disease Modifier
Nollet, E. E., Westenbrink, B. D., de Boer, R. A., Kuster, D. W. D., & van der Velden, J. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.018641 · Cited by 44
Dilated Cardiomyopathy: A Disease of the Myocardium
Sanbe, A. (2013) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b212023 · Cited by 42
Management of Hypertrophic Cardiomyopathy
Enriquez, A. D., & Goldman, M. E. (2014) · Annals of Global Health · doi:10.1016/j.aogh.2013.12.004 · Cited by 42
Guidelines for Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy (JCS 2012) – Digest Version –
JCS Joint Working Group (2016) · Circulation Journal · doi:10.1253/circj.cj-66-0122 · Cited by 40
Identification of biomarkers correlated with hypertrophic cardiomyopathy with co‐expression analysis
Chen, R., Ge, T., Jiang, W., Huo, J., Chang, Q., Geng, J., & Shan, Q. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28762 · Cited by 38
Targeted next-generation sequencing helps to decipher the genetic and phenotypic heterogeneity of hypertrophic cardiomyopathy
Cecconi, M., Parodi, M. I., Formisano, F., Spirito, P., Autore, C., Musumeci, B., Favale, S., Forleo, C., Rapezzi, C., Biagini, E., et al. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2732 · Cited by 37
LncRNA‐MIAT regulates fibrosis in hypertrophic cardiomyopathy (HCM) by mediating the expression of miR‐29a‐3p
Zhou, J., Zhou, Y., & Wang, C. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28001 · Cited by 38
Ion Channel Impairment and Myofilament Ca2+ Sensitization: Two Parallel Mechanisms Underlying Arrhythmogenesis in Hypertrophic Cardiomyopathy
Santini, L., Coppini, R., & Cerbai, E. (2021) · Cells · doi:10.3390/cells10102789 · Cited by 38
Chasing Mendel: five questions for personalized medicine
Joyner, M. J., & Prendergast, F. G. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2014.272336 · Cited by 37
Mutation-specific pathology and treatment of hypertrophic cardiomyopathy in patients, mouse models and human engineered heart tissue
Wijnker, P. J. M., & van der Velden, J. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165774 · Cited by 34
Hypertrophic Cardiomyopathy With Longevity to 90 Years or Older
Maron, B. J., Casey, S. A., Haas, T. S., Kitner, C., Garberich, R., & Lesser, J. R. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.12.027 · Cited by 35
Arrhythmogenic Cardiomyopathy
Saffitz, J. E. (2011) · Circulation · doi:10.1161/circulationaha.111.064022 · Cited by 34
Arrhythmogenic potential of myocardial disarray in hypertrophic cardiomyopathy: genetic basis, functional consequences and relation to sudden cardiac death
Finocchiaro, G., Sheikh, N., Leone, O., Westaby, J. D., Mazzarotto, F., Pantazis, A. A., Ferrantini, C., Sacconi, L., Papadakis, M., Sharma, S., et al. (2020) · EP Europace · doi:10.1093/europace/euaa348 · Cited by 35
Cardiomyopathy Classification: Ongoing Debate in the Genomics Era
McCartan, C., Mason, R., Jayasinghe, S. R., & Griffiths, L. R. (2012) · Biochemistry Research International · doi:10.1155/2012/796926 · Cited by 31
Disopyramide for Hypertrophic Cardiomyopathy: A Pragmatic Reappraisal of an Old Drug
Verlinden, N. J., & Coons, J. C. (2015) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1664 · Cited by 29
Multi-Omics Profiling of Hypertrophic Cardiomyopathy Reveals Altered Mechanisms in Mitochondrial Dynamics and Excitation–Contraction Coupling
Moore, J., Ewoldt, J. K., Venturini, G., Pereira, A. C., Padilha, K., Lawton, M. L., Lin, W., Goel, R. K., Luptak, I., Perissi, V., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054724 · Cited by 28
A One Health Approach to Hypertrophic Cardiomyopathy.
Ueda, Y., & Stern, J. A. (2017) · Europe PMC (PubMed Central) · Cited by 26
Genotype-phenotype Correlations of Hypertrophic Cardiomyopathy When Diagnosed in Children, Adolescents, and Young Adults
Loar, R. W., Bos, J. M., Will, M. L., Ommen, S. R., & Ackerman, M. J. (2015) · Congenital Heart Disease · doi:10.1111/chd.12280 · Cited by 28
Self-citation
ECG-derived spatial QRS-T angle is strongly associated with hypertrophic cardiomyopathy
Cortez, D., Schlegel, T. T., Ackerman, M. J., & Bos, J. M. (2016) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2016.10.001 · Cited by 25
Self-citation
Onset of Apical Hypertrophic Cardiomyopathy in Adulthood
Maron, B. J., Haas, T. S., Kitner, C., & Lesser, J. R. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.07.048 · Cited by 24
Modelling genetic diseases for drug development: Hypertrophic cardiomyopathy
Santini, L., Palandri, C., Nediani, C., Cerbai, E., & Coppini, R. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105176 · Cited by 24
Genomic Insights into Cardiomyopathies: A Comparative Cross-Species Review
Simpson, S., Rutland, P., & Rutland, C. S. (2017) · Veterinary Sciences · doi:10.3390/vetsci4010019 · Cited by 24
Somatic MYH7, MYBPC3, TPM1, TNNT2 and TNNI3 Mutations in Sporadic Hypertrophic Cardiomyopathy
Núñez, L., Gimeno, J. R., Rodriguez-Garcia, M. I., Monserrat, L., Zorio, E., COATS, C. J., McGregor, C. G. A., del Rincón, J. P. H., Castro‐Beiras, A., & Hermida‐Prieto, M. (2013) · Circulation Journal · doi:10.1253/circj.cj-13-0294 · Cited by 23
Left Ventricular Hypertrophy in Rhesus Macaques (Macaca mulatta) at the California National Primate Research Center (1992-2014).
Reader, J. R., Canfield, D. R., Lane, J. F., Kanthaswamy, S., Ardeshir, A., Allen, A. M., & Tarara, R. P. (2016) · PubMed Central · Cited by 23
Resequencing the Whole MYH7 Gene (Including the Intronic, Promoter, and 3′ UTR Sequences) in Hypertrophic Cardiomyopathy
Coto, E., Reguero, J. R., Palacín, M., Gómez, J., Alonso, B., Iglesias, S., Martı́n, M., Tavira, B., Molina, B. D., Morales, C., et al. (2012) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2012.04.001 · Cited by 23
The Prognostic Implications of Two-Dimensional Speckle Tracking Echocardiography in Hypertrophic Cardiomyopathy
Zegkos, T., Parcharidou, D. G., Ntelios, D., Efthimiadis, G. K., & Karvounis, H. I. (2017) · Cardiology in Review · doi:10.1097/crd.0000000000000172 · Cited by 21
Mutations in the cardiac troponin T gene show various prognoses in Japanese patients with hypertrophic cardiomyopathy
Fujita, E., Nakanishi, T., Nishizawa, T., Hagiwara, N., & Matsuoka, R. (2013) · Heart and Vessels · doi:10.1007/s00380-013-0332-3 · Cited by 20
The Achilles’ Heel of Cardiovascular Genetic Testing: Distinguishing Pathogenic Mutations From Background Genetic Noise
Landstrom, A. P., & Ackerman, M. J. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.192 · Cited by 20
Self-citation
The Ups and Downs of Genetic Diagnosis of Hypertrophic Cardiomyopathy
Gómez, J., Reguero, J. R., & Coto, E. (2015) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2015.10.001 · Cited by 19
A Haplotype of Two Novel Polymorphisms in δ-Sarcoglycan Gene Increases Risk of Dilated Cardiomyopathy in Mongoloid Population
Chen, J., Jin, Y., Wang, H., Wei, S., Chen, D., Li, Y., Zhou, Q., Li, G., Li, J., Gao, J., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0145602 · Cited by 19
Usefulness of Genetic Testing in Hypertrophic Cardiomyopathy: an Analysis Using Real-World Data
Restrepo-Córdoba, M. A., Campuzano, Ó., Ripoll‐Vera, T., Marcos, M. C., Mademont‐Soler, I., Martínez, J. M. G., Domínguez, F., González-López, E., Padrón-Barthe, L., Lara‐Pezzi, E., et al. (2017) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-017-9730-8 · Cited by 19
THE NEW GENOME VARIANTS IN RUSSIAN CHILDREN WITH GENETICALLY DETERMINED CARDIOMYOPATHIES REVEALED WITH MASSIVE PARALLEL SEQUENCING
Savostyanov, K. V., Namazova-Baranova, L. S., Basargina, E. N., Vashakmadze, N. D., Zhurkova, N. V., Pushkov, A. A., Сергеевич, Ж. И., Sdvigova, N. A., Lukanina, V. Y., & Nikitin, A. G. (2017) · Annals of the Russian academy of medical sciences · doi:10.15690/vramn872 · Cited by 19
The clinical utility of pediatric cardiomyopathy genetic testing: From diagnosis to a precision medicine-based approach to care
Parker, L. E., & Landstrom, A. P. (2021) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2021.101413 · Cited by 18
Self-citation
Cardiomyopathy: pathogenesis and therapeutic interventions
Huang, S., Li, J., Li, Q., Wang, Q., Zhou, X., Chen, J., Chen, X., Bellou, A., Zhuang, J., & Lei, L. (2024) · MedComm · doi:10.1002/mco2.772 · Cited by 20
Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction: Expecting the Unexpected
Jain, P., Patel, P. A., & Fabbro, M. (2017) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2017.04.054 · Cited by 17
Clinical prediction of genotypes in hypertrophic cardiomyopathy: A systematic review
Aziz, A., Musiol, S., Moody, W. E., Pickup, L. C., Cooper, R. M., & Lip, G. Y. H. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13593 · Cited by 16
The 25-Year Genetic Era in Hypertrophic Cardiomyopathy: Revisited
Maron, B. J., & Maron, M. S. (2014) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.114.000741 · Cited by 16
Luces y sombras en el diagnóstico genético de la miocardiopatía hipertrófica
Gómez, J., Reguero, J. R., & Coto, E. (2015) · Revista Española de Cardiología · doi:10.1016/j.recesp.2015.10.003 · Cited by 15
Hypertrophic cardiomyopathy: single gene disease or complex trait?
Helms, A. S., & Day, S. M. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv562 · Cited by 15
Inherited cardiomyopathies—Novel therapies
Leviner, D. B., Hochhauser, E., & Arad, M. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.08.003 · Cited by 15
Fibrosis and Ventricular Arrhythmogenesis
Shenasa, M. (2019) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2019.06.002 · Cited by 14
Precision medicine validation: identifying the MYBPC 3 A31P variant with whole-genome sequencing in two Maine Coon cats with hypertrophic cardiomyopathy
Ontiveros, E. S., Ueda, Y., Harris, S. P., & Stern, J. A. (2018) · Journal of Feline Medicine and Surgery · doi:10.1177/1098612x18816460 · Cited by 12
Identification of an elusive spliceogenic MYBPC3 variant in an otherwise genotype-negative hypertrophic cardiomyopathy pedigree
Torrado, M., Maneiro, E., Lamounier, A., Fernández‐Burriel, M., Giralt, S. S., Martínez-Carapeto, A., Cazón, L., Santiago, E., Ochoa, J. P., McKenna, W. J., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-11159-y · Cited by 12
Genetic diagnosis in pediatric cardiomyopathy: Clinical application and research perspectives
Ware, S. M. (2011) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2011.02.006 · Cited by 12
Recent advances in hypertrophic cardiomyopathy
Yingchoncharoen, T., & Tang, W. H. W. (2014) · F1000Prime Reports · doi:10.12703/p6-12 · Cited by 12
The expanding role of epigenetics
Kalozoumi, G., Tzimas, C., & Sanoudou, D. (2012) · Global Cardiology Science and Practice · doi:10.5339/gcsp.2012.7 · Cited by 12
HYPERTROPHIC CARDIOMYOPATHY: GENETIC ALTERATIONS, PATHOGENESIS AND PATHOPHYSIOLOGY
Vatutin, N. T., Тарадин, Г. Г., & Maron, M. S. (2014) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2014-5-35-42 · Cited by 11
Genetic Variation Screening of TNNT2 Gene in a Cohort of Patients With Hypertrophic and Dilated Cardiomyopathy
Jáchymová, M., Muravská, A., Paleček, T., Kuchynka, P., ŘEHÁKOVÁ, H., Magage, S., Král, A., Zima, T., Horký, K., & Linhart, A. (2012) · Physiological Research · doi:10.33549/physiolres.932157 · Cited by 11
Prevalence and Phenotypic Expression of Mutations in the MYH7, MYBPC3 and TNNT2 Genes in Families with Hypertrophic Cardiomyopathy in the South of Brazil: A Cross-Sectional Study
Mattos, B. P. E., Scolari, F. L., Torres, M. A. R., Simon, L., de Freitas, V. C., Giugliani, R., & Matte, Ú. D. S. (2016) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20160133 · Cited by 11
Septal myectomy for hypertrophic cardiomyopathy: important surgical knowledge and technical tips in the era of increasing alcohol septal ablation
Chiang, Y. P., Shimada, Y. J., Ginns, J. N., Weiner, S. D., & Takayama, H. (2018) · General Thoracic and Cardiovascular Surgery · doi:10.1007/s11748-018-0895-0 · Cited by 11
The G263X MYBPC3 mutation is a common and low-penetrant mutation for hypertrophic cardiomyopathy in the region of Asturias (Northern Spain)
Reguero, J. R., Gómez, J., Martı́n, M., Flórez, J. P., Morı́s, C., Iglesias, S., Alonso, B., Álvarez, V., & Coto, E. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.06.085 · Cited by 10
Echocardiographic characterization of hypertrophic cardiomyopathy in Chinese patients with myosin-binding protein C3 mutations
Zhao, B., Wang, S., Chen, J., Ji, Y., Wang, J., Tian, X., & Zhi, G. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4089 · Cited by 10
Hypertrophic Cardiomyopathy: Challenging the Status Quo?
Younger, J. F., Lo, A., McCormack, L., McGaughran, J. M., Prasad, S. B., & Atherton, J. J. (2019) · Heart Lung and Circulation · doi:10.1016/j.hlc.2019.12.005 · Cited by 10
Percutaneous Septal Ablation in Hypertrophic Obstructive Cardiomyopathy: From Experiment to Standard of Care
Faber, L. (2014) · Advances in Medicine · doi:10.1155/2014/464851 · Cited by 9
Compound Mutation in Cardiac Sarcomere Proteins Is Associated with Increased Risk for Major Arrhythmic Events in Pediatric Onset Hypertrophic Cardiomyopathy
Pollmann, K., Kaltenecker, E., Schleihauf, J., Ewert, P., Görlach, A., & Wolf, C. M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10225256 · Cited by 9
Risk stratification in pediatric hypertrophic cardiomyopathy: Insights for bridging the evidence gap?
Nakano, S. J., & Menon, S. C. (2018) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2018.03.001 · Cited by 8
Diagnosis of Heart Failure
Clerkin, K. J., MANCINI, D. M., & Lund, L. H. (2019) · Cardiovascular medicine · doi:10.1007/978-3-319-98184-0_6 · Cited by 8
Hypertrophic Cardiomyopathy: The Past, the Present, and the Future
D, E. B. M. (2014) · Springer eBooks · doi:10.1007/978-1-4471-4956-9_1 · Cited by 8
Using Genetic Testing to Guide Therapeutic Decisions in Cardiomyopathy
Lakdawala, N. K. (2013) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-013-0252-7 · Cited by 8
Proteomic Characterisation of Heart Failure Reveals a Unique Molecular Phenotype for Hypertrophic Cardiomyopathy
Tonry, C. L., Linden, K., Collier, P. H., Ledwidge, M. T., McDonald, K., Collins, B. C., & Watson, C. J. (2024) · Biomedicines · doi:10.3390/biomedicines12081712 · Cited by 7

Malignant mutations in hypertrophic cardiomyopathy: fact or fancy?
Brito, D. A., & Madeira, H. C. (2005) · PubMed · Cited by 12
Prognostic predictive value of gene mutations in Japanese patients with hypertrophic cardiomyopathy
Chida, A., Inai, K., Sato, H., Shimada, E., Nishizawa, T., Shimada, M., Furutani, M., Furutani, Y., Kawamura, Y., Sugimoto, M., et al. (2016) · Heart and Vessels · doi:10.1007/s00380-016-0920-0 · Cited by 22
Prevalence and Severity of “Benign” Mutations in the β-Myosin Heavy Chain, Cardiac Troponin T, and α-Tropomyosin Genes in Hypertrophic Cardiomyopathy
Driest, S. L. V., Ackerman, M. J., Ommen, S. R., Shakur, R., Will, M. L., Nishimura, R. A., Tajik, A. J., & Gersh, B. J. (2002) · Circulation · doi:10.1161/01.cir.0000042675.59901.14 · Cited by 180
Self-citation
Risk stratification in hypertrophic cardiomyopathy
Vassalli, G., Seiler, C. A., & Hess, O. M. (1994) · Current Opinion in Cardiology · doi:10.1097/00001573-199405000-00011 · Cited by 21
Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin t genes in hypertrophic cardiomyopathy
Ackerman, M. J., VanDriest, S. L., Ommen, S. R., Will, M. L., Nishimura, R. A., Tajik, A. J., & Gersh, B. J. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01900-9 · Cited by 235
Self-citation

Authors: Landstrom, A. P., & Ackerman, M. J.
Affiliations: Mayo Clinic (US)
ORCID: Landstrom, Andrew P.
Ackerman, Michael J.
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2010-12-07
Volume: 122
Issue: 23
Pages: 2441-2450
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/circulationaha.110.954446
PMC: PMC6309993
OpenAlex: W2089547093
Cited by: 146
References: 66
Citations by year: 2026: 3 · 2025: 5 · 2024: 5 · 2023: 5 · 2022: 4 · 2021: 11 · 2020: 10 · 2019: 6 · 2018: 7 · 2017: 14 · 2016: 6 · 2015: 13 · 2014: 21 · 2013: 14 · 2012: 15
FWCI: 7.90
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: Mayo Clinic
National Institutes of Health (5p01hl094291-05)
National Heart, Lung, and Blood Institute (1P01HL094291, P01‑HL094291)
National Institute of General Medical Sciences (T32GM072474)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
Keywords: hypertrophic cardiomyopathy, mutation types, prognosis, risk stratification, MYH7, beta-myosin heavy chain, TNNT2, cardiac troponin T, sudden cardiac death, genotype-phenotype correlation, genetic heterogeneity, inherited cardiovascular disease, biomarkers, genotype-phenotype discordance, genotype-phenotype concordance
MeSH terms: Cardiomyopathy, Hypertrophic, Genotype, Humans, Mutation, Predictive Value of Tests, Prognosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Mutation Type Is Not Clinically Useful in Predicting Prognosis in Hypertrophic Cardiomyopathy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks